Prognostic role of lymph node micrometastasis in oral and oropharyngeal cancer: A systematic review.

Immunohistochemistry Isolated tumor cells Micrometastasis Neck dissection Oral and oropharyngeal cancer Sentinel lymph node Systematic review

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
31 May 2024
Historique:
received: 06 02 2024
revised: 02 04 2024
accepted: 10 04 2024
medline: 2 6 2024
pubmed: 2 6 2024
entrez: 1 6 2024
Statut: aheadofprint

Résumé

An estimated 20% of patients with oral and oropharyngeal squamous cell carcinoma (OOSCC) have micrometastases (Mi) or isolated tumor cells (ITC) in the cervical lymph nodes that evade detection by standard histological evaluation of lymph node sections. Lymph node Mi and ITC could be one reason for regional recurrence after neck dissection. The aim of this study was to review the existing data regarding the impact of Mi on the survival of patients with OOSCC. PubMed and the Cochrane Library were searched for articles reporting the impact of Mi and ITC on patient survival. Two authors independently assessed the methodological quality of retrieved studies using the Downs and Black index. Data were also extracted on study type, number of included patients, mode of histological analysis, statistical analysis, and prognostic impact. Sixteen articles with a total of 2064 patients were included in the review. Among the 16 included studies, eight revealed a statistically significant impact of Mi on at least one endpoint in the Kaplan-Meier and/or multivariate analysis. Three studies regarded Mi as Ma, while five studies found no impact of Mi on survival. Only one study demonstrated an impact of ITC on patient's prognosis in the univariate but not in the multivariate analysis. The majority of cases included in the review were patients with oral cancer. The findings provide low-certainty evidence that Mi negatively impacts survival. Data on ITC were scarcer, so no conclusions can be drawn about their effect on survival. The lower threshold to discriminate between Mi and ITC should be defined for OOSCC since the existing thresholds are based on data from different tumors. The histological, immunohistological, and anatomical characteristics of Mi and ITC in OOSCC as well as the effect of radiotherapy on Mi should be further investigated separately for oral and oropharyngeal carcinomas.

Sections du résumé

BACKGROUND BACKGROUND
An estimated 20% of patients with oral and oropharyngeal squamous cell carcinoma (OOSCC) have micrometastases (Mi) or isolated tumor cells (ITC) in the cervical lymph nodes that evade detection by standard histological evaluation of lymph node sections. Lymph node Mi and ITC could be one reason for regional recurrence after neck dissection. The aim of this study was to review the existing data regarding the impact of Mi on the survival of patients with OOSCC.
METHODS METHODS
PubMed and the Cochrane Library were searched for articles reporting the impact of Mi and ITC on patient survival. Two authors independently assessed the methodological quality of retrieved studies using the Downs and Black index. Data were also extracted on study type, number of included patients, mode of histological analysis, statistical analysis, and prognostic impact.
RESULTS RESULTS
Sixteen articles with a total of 2064 patients were included in the review. Among the 16 included studies, eight revealed a statistically significant impact of Mi on at least one endpoint in the Kaplan-Meier and/or multivariate analysis. Three studies regarded Mi as Ma, while five studies found no impact of Mi on survival. Only one study demonstrated an impact of ITC on patient's prognosis in the univariate but not in the multivariate analysis.
CONCLUSION CONCLUSIONS
The majority of cases included in the review were patients with oral cancer. The findings provide low-certainty evidence that Mi negatively impacts survival. Data on ITC were scarcer, so no conclusions can be drawn about their effect on survival. The lower threshold to discriminate between Mi and ITC should be defined for OOSCC since the existing thresholds are based on data from different tumors. The histological, immunohistological, and anatomical characteristics of Mi and ITC in OOSCC as well as the effect of radiotherapy on Mi should be further investigated separately for oral and oropharyngeal carcinomas.

Identifiants

pubmed: 38823172
pii: S1368-8375(24)00126-X
doi: 10.1016/j.oraloncology.2024.106808
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106808

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Paris Liokatis (P)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: Paris.liokatis@med.uni-muenchen.de.

Ioanna Liokati (I)

Department of Otorhinolaryngology, General Hospital Georgios Gennimatas, Athens, Greece. Electronic address: Ioannaliokati@gmail.com.

Katharina Obermeier (K)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: Katharina.obermeier@med.uni-muenchen.de.

Wenko Smolka (W)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: Wenko.smolka@med.uni-muenchen.de.

Fatma Ersan (F)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: fatma.ersan@campus.lmu.de.

Ina Dewenter (I)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: I.Dewenter@med.uni-muenchen.de.

Sven Otto (S)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: Sven.otto@med.uni-muenchen.de.

Poxleitner Philipp (P)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: philipp.poxleitner@med.uni-muenchen.de.

Birte Siegmund (B)

Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany. Electronic address: birte.siegmund@med.uni-muenchen.de.

Christoph Walz (C)

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany. Electronic address: Christoph.walz@med.uni-muenchen.de.

Till Braunschweig (T)

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany. Electronic address: Till.Braunschweig@med.uni-muenchen.de.

Frederick Klauschen (F)

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany. Electronic address: f.klauschen@lmu.de.

Andreas Mock (A)

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany. Electronic address: Andreas.mock@med.uni-muenchen.de.

Classifications MeSH